Insidertrades

Allogene Therapeutics

ALLO

Insider trades and stock quote 2024-2026

All insider trades at Allogene Therapeutics

Subscribe RSS
Date Type Insider Position Ø-Price Volume
8/21/2026 Sell Douglas, Earl Martin SVP, General Counsel $2.1 $62,958
4/21/2026 Sell Yoshiyama, Annie SVP, Finance $2.3 $22,144
3/31/2026 Sell Beneski, Benjamin Machinas SVP, Chief Technical Officer $2.5 $7,168
3/16/2026 Sell Chang, David D. President and CEO $2.5 $117,975
3/16/2026 Sell Beneski, Benjamin Machinas SVP, Chief Technical Officer $2.5 $11,942
3/2/2026 Sell Beneski, Benjamin Machinas SVP, Chief Technical Officer $2.6 $18,543
2/2/2026 Sell Douglas, Earl Martin SVP, General Counsel $1.8 $40,304
2/2/2026 Sell Roberts, Zachary EVP of R&D $1.8 $63,189
2/2/2026 Sell Yoshiyama, Annie SVP, Finance $1.7 $7,167
2/2/2026 Sell Parker, Geoffrey M. CHIEF FINANCIAL OFFICER $1.8 $42,242
2/2/2026 Sell Chang, David D. President and CEO $1.8 $171,484
2/2/2026 Sell Beneski, Benjamin Machinas SVP, Chief Technical Officer $1.7 $13,060
1/21/2026 Sell Roberts, Zachary EVP of R&D $1.6 $40,980
11/17/2025 Sell Beneski, Benjamin Machinas SVP, Chief Technical Officer $1.2 $959
10/21/2025 Sell Parker, Geoffrey M. CHIEF FINANCIAL OFFICER $1.3 $46,169
6/10/2025 Sell Messemer, Deborah M. Director $1.4 $52,377
4/21/2025 Sell Yoshiyama, Annie SVP, Finance $1.4 $13,537
3/14/2025 Sell Beneski, Benjamin Machinas SVP, Chief Technical Officer $2.0 $10,839
3/14/2025 Sell Chang, David D. President and CEO $2.0 $91,469
2/18/2025 Sell Messemer, Deborah M. Director $2.4 $32,351
2/3/2025 Sell Roberts, Zachary EVP of R&D $1.7 $32,014
2/3/2025 Sell Chang, David D. President and CEO $1.7 $77,285
2/3/2025 Sell Moore, Timothy L. Chief Technical Officer $1.7 $25,216
2/3/2025 Sell Parker, Geoffrey M. CHIEF FINANCIAL OFFICER $1.7 $7,545
2/3/2025 Sell Douglas, Earl Martin SVP, General Counsel $1.7 $10,951
1/21/2025 Sell Roberts, Zachary EVP of R&D $1.8 $48,414
12/9/2024 Sell Messemer, Deborah M. Director $2.2 $19,916
12/5/2024 Sell Humer, Franz B. Director $2.2 $19,917
Rows per page:
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)